Consolidated FAQs on the implementation of Council Regulation No 833/2014 and Council Regulation No 269/2014 [Version of 1 February 2023]

The European Commission (EC) has published an updated consolidated version of its „FAQs on the implementation of Council Regulation No 833/2014 and Council Regulation No 269/2014“ in the light of the ongoing conflict in Ukraine. The consolidated version includes FAQs concerning EU sanctions „adopted following Russia’s military aggression against Ukraine“.
The update includes the following changes:
1. Section „SECTOR SPECIFIC QUESTIONS“, topic 1 „MEDIA“:
a) New Question (page 259): Are there derogations to the prohibition for EU operators to sell listed channels in situations where this prohibition would affect sales of non-listed channels to the same client?
A: EU-based operators frequently offer “bouquets” of channels for sales. In situations where bouquets include both listed and non-listed channels, Council Regulation 833/2014 does not contain any derogation to the prohibition of Article 2f. Thus, it is prohibited for EU operators to sell this kind of bouquets.
b) New Question (page 259): Are there derogations to the prohibition for EU operators to sell listed channels in situations where this prohibition would affect sales to public entities?
A: There is no derogation nor exemption to Article 2f of Council Regulation 833/2014 in case of sales to public entities.
2. Section „SECTOR SPECIFIC QUESTIONS“, topic 12 „MEDICINES AND MEDICAL DEVICES“:
a) Modified Question (page 343): Is there a definition of ‘medical’ or pharmaceutical purposes’ as per the exceptions under Article 2(3)(b), Article 2a(3)(b), Article 3k(5)(a)?
A: EU sanctions do not include a definition of ‘medical’ or ‘pharmaceutical purposes’.
b) Modified Question (page 344): Is there a definition of pharmaceutical and medical products as per the exceptions under Articles 3l(4)(b), Article 3ea(5)(b) and Article 5aa(3)(f)?
A: EU sanctions do not include a definition of ‘pharmaceutical and medical products’.